Anaplastic Large Cell Lymphoma, ALK-Positive

specific

A T-cell peripheral lymphoma composed of usually large, pleomorphic, CD30 positive T-lymphocytes with abundant cytoplasm. It is characterized by the presence of a translocation involving the ALK gene and expression of ALK fusion protein. Most patients present with peripheral and/or abdominal lymphadenopathy, and often have advanced disease and extranodal involvement.

Centers

Active Trials

—

Cancer Funding

Top Centers for Anaplastic Large Cell Lymphoma, ALK-Positive(56)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	70.6
2	University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	70.6
3	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical High-Volume Research Center	High-Volume Research Center	2	—	70.6
4	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical High-Volume Research Center	High-Volume Research Center	2	—	70.6
5	University of Illinois Cancer CenterChicago, IL High-Volume Research Center	High-Volume Research Center	2	—	70.6
6	Boston University Cancer CenterBoston, MA High-Volume Research Center	High-Volume Research Center	2	—	70.6
7	Cancer Center at IllinoisUrbana, IL High-Volume Research Center	High-Volume Research Center	2	—	70.6
8	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
9	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
10	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
11	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
12	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
13	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
14	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
15	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
16	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
17	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
18	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
19	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
20	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
21	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
22	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
23	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	60.5
24	BC CancerVancouver, BC Active Research Program	Active Research Program	1	—	60.5
25	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	1	—	60.5
26	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		—	—	40.8
27	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	—	40.8
28	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		—	—	40.8
29	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	40.8
30	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	—	40.8
31	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	—	40.8
32	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive		—	—	40.8
33	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	40.8
34	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive		—	—	40.8
35	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive		—	—	40.8
36	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	40.8
37	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		—	—	40.8
38	Medical College of Wisconsin Cancer CenterMilwaukee, WI		—	—	40.8
39	Cedars-Sinai CancerLos Angeles, CA		—	—	40.8
40	Cleveland Clinic Cancer CenterCleveland, OH		—	—	40.8
41	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	—	40.8
42	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive		—	—	40.8
43	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	40.8
44	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive		—	—	40.8
45	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	40.8
46	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	—	40.8
47	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	—	40.8
48	Penn State Cancer InstituteHershey, PA		—	—	40.8
49	University of Cincinnati Cancer CenterCincinnati, OH		—	—	40.8
50	Livestrong Cancer InstitutesAustin, TX		—	—	40.8
51	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	40.8
52	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ		—	—	40.8
53	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	—	40.8
54	Upstate Cancer CenterSyracuse, NY		—	—	40.8
55	Loma Linda University Cancer CenterLoma Linda, CA		—	—	40.8
56	Louisiana Cancer Research CenterNew Orleans, LA		—	—	40.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →